Profound Medical Corp.: Business Overview, Financials & Competitive Analysis
Profound Medical Corp. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Early-stage medical device company with innovative MRI-guided ultrasound platform showing revenue traction but facing cash burn and commercialization scaling challenges. In 2024, Profound Medical's revenue was $10.68 million, an increase of 48.35% compared to the previous year. However, the company faces significant losses and remains in early commercial stage.
What is Profound Medical Corp.'s industry? Profound Medical Corp. (profoundmedical.com) operates in Medical Devices - Minimally Invasive Therapeutics. AskCyborg classifies Profound Medical Corp. under Medical Devices - Minimally Invasive Therapeutics in its company registry.
Profound Medical Corp is a medical technology company focused on a therapeutics platform that provides the precision of real-time Magnetic Resonance Imaging combined with the safety and ablation power of directional a...
Cyborg Score thesis
Early-stage medical device company with innovative MRI-guided ultrasound platform showing revenue traction but facing cash burn...
Read the full analyst-debate transcript →Get the Latest Profound Medical Corp. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeProfound Medical Corp. Overview
Pro stress-test →Profound Medical Corp is a medical technology company focused on a therapeutics platform that provides the precision of real-time Magnetic Resonance Imaging combined with the safety and ablation power of directional and focused ultrasound technology for the incision-free ablation of diseased tissue. The company is commercializing TULSA-PRO for prostate treatment and Sonalleve for soft tissue applications across multiple markets.
Strategic Profile
Pro stress-test →Profound is commercializing TULSA-PRO, a technology that combines real-time MRI, AI-enhanced planning, robotically-driven transurethral ultrasound and closed-loop temperature feedback control with potential to become a mainstream treatment modality across the entire prostate disease spectrum. The company recently regained exclusive distribution rights for TULSA-PRO in Canada.
Competitive Landscape
Pro stress-test →Profound Medical competes in the minimally-invasive therapeutic ablation space. Key competitors include focused ultrasound and thermal ablation device makers targeting prostate, soft tissue and oncology applications. The company differentiates through real-time MRI guidance and AI-enhanced planning for precision ablation.
Industry Context
Profound Medical Corp. operates in Medical Devices - Minimally Invasive Therapeutics.
Key facts
Founded: 2008 · Headquarters: Mississauga, Ontario, Canada · Revenue: $10.68M (2024)